Bank of Montreal’s Clovis Oncology, Inc. CLVS Stock Holding History

Bank of Montreal’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100,400	Closed	-$122	–	4515
2022 Q3	$122	Buy	100,400 +2,100	+2%	+$3.27K	﹤0.01%	3395
2022 Q2	$168	Buy	+98,300	New	+$145K	﹤0.01%	3329
2021 Q1	–	Sell	-10,200	Closed	-$57K	–	5444
2020 Q4	$57K	Sell	10,200 -40,600	-80%	-$205K	﹤0.01%	3885
2020 Q3	$285K	Sell	50,800 -83,800	-62%	-$501K	﹤0.01%	2576
2020 Q2	$902K	Buy	134,600 +70,500	+110%	+$534K	﹤0.01%	1981
2020 Q1	$389K	Sell	64,100 -36,700	-36%	-$294K	﹤0.01%	2089
2019 Q4	$1.05M	Buy	100,800 +4,400	+5%	+$32K	﹤0.01%	2246
2019 Q3	$379K	Buy	+96,400	New	+$780K	﹤0.01%	2568
2017 Q1	–	Sell	-3,800	Closed	-$130K	–	4261
2016 Q4	$130K	Sell	3,800 -900	-19%	-$31.7K	﹤0.01%	2712
2016 Q3	$169K	Buy	+4,700	New	+$101K	﹤0.01%	2517

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Bank of Montreal's CLVS Position: Q4 2022 in Review

Bank of Montreal sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 111,750 shares — an estimated $136 sold.

Bank of Montreal first reported a position in CLVS in Q2 2014 and held it in 29 quarters. The position peaked at $1.06M in Q3 2018. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Bank of Montreal reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Bank of Montreal sold 111,750 Clovis Oncology, Inc. shares in Q4 2022, an estimated $136.
Bank of Montreal first reported a position in Clovis Oncology, Inc. in Q2 2014 and held it in 29 quarters.
Bank of Montreal's Clovis Oncology, Inc. position peaked at $1.06M in Q3 2018.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.